Nutr Res Pract.  2009 Mar;3(1):23-30.

Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats

• Jeong H
• Kwon HJ
• Kim MK

Abstract

The aim of this study was to examine the hypoglycemic effect of chlorella in 6 week-old type 2 diabetic Goto-Kakizaki (GK, n=30) rats and 6 week-old normal Wistar (n=30) rats. Animals were randomly assigned to 3 groups respectively, and were fed three different experimental diets containing 0%, 3% or 5% (w/w) chlorella for 8 weeks. In diabetic GK rats, the insulinogenic-indices were not significantly different among the groups. The concentrations of fasting plasma glucagon and hepatic triglyceride, and the insulin/glucagon ratios of the GK-3% chlorella and GK-5% chlorella groups were significantly lower than those of the GK-control group. The HOMA-index and the concentrations of fasting blood glucose and plasma insulin of the GK-3% chlorella and GK-5% chlorella groups were slightly lower than those of the GK-control group. In normal Wistar rats, the insulinogenic-indices were not significantly different among the normal groups, but that of the Wistar-5% chlorella group was slightly higher than the other groups. The concentrations of fasting blood glucose and plasma insulin, and the HOMA-index of the Wistar-5% chlorella group were a little higher, and the fasting plasma glucagon concentration and the insulin/glucagon ratio of the Wistar-5% chlorella group were significantly higher than those of the Wistar-control and Wistar-3% chlorella groups. In conclusion, this study shows that the glucose-stimulated insulin secretion was not affected by the intake of chlorella, which could be beneficial, however, in improving insulin sensitivity in type 2 diabetic GK and normal Wistar rats.

Keyword

Chlorella; glucagon; Goto-kakizaki rat; insulin; insulin sensitivity

MeSH Terms

Animals
Blood Glucose
Chlorella
Chlorella vulgaris
Diet
Fasting
Glucagon
Hypoglycemic Agents
Insulin
Insulin Resistance
Plasma
Rats
Rats, Wistar
Blood Glucose
Glucagon
Hypoglycemic Agents
Insulin

Reference

1. Asano T, Yoshida R, Ogata H, Kokawa K, Ogimoto M, Akehi Y, Anzai K, Ono J, Tamura K, Hidehira K, Kikuchi M. Beta-Cell Function is a Major Contributor to Oral Glucose Disposition in Obese Japanese Students. Endocr J. 2007. 54:903–910.

2. Bernard P. Programmed disorders of β-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev. 2005. 21:495–504.

3. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959. 37:911–917.

4. Boden G, Chen X, Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes. 1998. 47:1609–1612.

5. Briones M, Bajaj M. Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus. Expert Opin Pharmacother. 2006. 7:1055–1064.

6. Chen MS, Kao CS, Chang CJ. Prevalence and risk factors of diabetic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol. 1991. 114:723–730.

7. Cherng JY, Shih MF. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci. 2005a. 77:980–990.

8. Cherng JY, Shih MF. Preventing dyslipidemia by chlorella pyrenoidosa in rats and hamster after chronic high fat diet treatment. Life Sci. 2005b. 76:3001–3013.

9. Cherng JY, Shih MF. Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci. 2006. 78:1181–1186.

10. Choi KH, Song KH, Lee SH, Chung SH, Kin EJ, Ko SH, Kwon HS, Ahn YB, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK. Relative hyperglucagonemia and its related factors in patients with type 2 diabetes. The Journal of the Korean Diabetes Association. 2004. 28:338–345.

11. Egan JM, Clocquet AR, Elahi D. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab. 2002. 87:1282–1290.

12. Fanelli CG, Porcellati F, Rossetti P, Bolli GB. Glucagon: The effects of its excess and deficiency on insulin action. Nutr Metab Cardiovasc Dis. 2006. 16:S28–S34.

13. Ferrannini E, Muscelli E, Natali A, Gabriel R, Mitrakou A, Flyvbjerg A, Golay A, Hojlund k. Relationship between Insulin Sensitivity and Cardiovascular Disease Risk (RISC) Project Investigators. Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia. 2007. 50:2342–2347.

14. Fossati P, Prencipe L. Serum glycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982. 28:2077–2080.

15. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998. 339:229–234.

16. Han JG, Kang GG, Kim JK, Kim SH. The present status and future of chlorella. Food Science and Industry. 2002. 6:64–69.

17. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasmaglucose levels in U.S. population aged 20-74 yr. Diabetes. 1987. 36:523–534.

18. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003. 284:E671–E678.

19. Jue Li, Takashi Kaneko, Li-Qiang Qin, Jing Wang, Yuan Wang, Akio Sato. Long-term effects of high dietary fiber intake on glucose tolerance and lipid metabolism in GK rats: Comparison among Barley, Rise and Cornstarch. Metabolism. 2003. 53:1206–1210.

20. Kang MS, SIm AJ, Chae HJ. Chlorella as a functional biomaterial. Korean J Biotechnol Bioeng. 2004. 19:1–11.

21. Keen H. What's in a name? IDDM/NIDDM. Type 1/type 2. Diabet Med. 1986. 3:11–12.

22. Kim MK, Paek JE. Effect of dietary fibers in rice and barely on lipid and cadmium metabolism in the rat. The Korean Journal of Nutrition. 1997. 26:21–33.

23. Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2002. 88:3082–3089.

24. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol. 1957. 3:447–454.

25. Mahler RJ, Adler ML. Type 2 diabetes mellitus : update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab. 1999. 84:1165–1171.

26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985. 28:412–419.

27. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for colorimetric determination of serum triglycerides. Clin Chem. 1983. 29:538–542.

28. Ministry of Health and Welfare. Report on 1998 National Health and Nutrition Survey: Nutrition Survey. 1999. Seoul. Republic of Korea:

29. Ministry of Health and Welfare. Report on 2005 National Health and Nutrition Survey: Nutrition Survey. 2006. Seoul. Republic of Korea:

30. Nunes E, Peixoto F, Louro T, Sena CM, Santos MS, Matafome P, Moreira PI, Seica R. Soybean oil treatment impairs glucose-stimulated insulin secretion and changes fatty acidcomposition of normal and diabetic islets. Acta Diabetol. 2007. 44:121–130.

31. Nutrition Research Council. Nutrient requirements of laboratory animals. 1995. Seoul. Republic of Korea: The academy press.

32. Park SM. Strategies for development of anti-diabetic functional foods. Food Science and Industry. 2007. 40:46–58.

33. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia. 2002. 44:929–945.

34. Reaven GM, Chang H, Ho H, Jeng CY, Hoffman BB. Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am J Physiol. 1988. 254:E23–E30.

35. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodent : Final report of the American Institute Nutrition Ad Hoc wrighting Committee on the reformulation of the AIN-79A rodent diet. J Nutr. 1993. 123:1939–1951.

36. Reitman A, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetatic and glutamic pyruvic transaminase. Am J Clin Pathol. 1957. 28:56–63.

37. Rhee BD. Epidemiological characteristics of diabetes mellitus among korean population. The Journal of the Korean Diabetes Association. 2003. 27:173–178.

38. Roden M, Price PB, Perseghin G, Petersen KF, Pothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in human. J Clin Invest. 1996. 97:2859–2865.

39. Rodiriguez-Lopez M. Action of the chlorella pyrenoidosa on experimental diabetes in rats. Med Exp Int J Exp Med. 1964. 10:381–386.

40. Rodríguez-López M, López-Quijada C. Plasma-glucose and plasma-insulin in normal and alloxanized rats treated with Chlorella. Life Sci II. 1971. 10:57–60.

41. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR, Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1991. 34:409–415.

42. Sano T, Kumamoto Y, Kamiya N, Okuda M, Tanaka Y. Effect of lipophilic extract on Chlorella vulgaris on alimentary hyperlipidemia in cholesterol-fed rats. Artery. 1988. 15:217–224.

43. Simonson GD, Kendalla DM. Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus. Coron Artery Dis. 2005. 16:465–472.

44. Smith C, Marks AD, Lieberman M. Basic medical biochemistry. 2005. Baltimore. USA: Lippincott Williams & Wilkins;478–479.

45. Song KE, Kim DJ, Park JW, Cho HK, Lee KW, Huh KB. Clinical characteristics of Korean type 2 diabetic patients according to insulin secretion and insulin resistance. The Journal of the Korean Diabetes Association. 2007. 31:123–129.

46. The Koreas Society of Food Science and Nutrition. Handbook of experiments in food science and nutrition. 2000. Seoul. Republic of Korea: Hyoil Press;661.

47. Unger RH. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism. 1978. 27:1691–1709.

48. Wakasugi K. Glucagon degrading activity. Nippon Naibunpi Gakkai Zasshi. 1989. 65:483–496.

49. Webster D, Bignell AH, Attwood EC. An assessment of the suitability of bromocresol green for the determination of serum albumin. Clin Chim Acta. 1974. 53:101–108.

50. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004. 27:1047–1053.